Upmc Presbyterian - Renal Unit is a medicare approved dialysis facility center in Pittsburgh, Pennsylvania and it has 12 dialysis stations. It is located in Allegheny county at 200 Lothrop Street, Pittsburgh, PA, 15213. You can reach out to the office of Upmc Presbyterian - Renal Unit at (412) 647-3114. This dialysis clinic is managed and/or owned by Upmc Health System. Upmc Presbyterian - Renal Unit has the following ownership type - Non-Profit. It was first certified by medicare in June, 2004. The medicare id for this facility is 390164 and it accepts patients under medicare ESRD program.
| Name | Upmc Presbyterian - Renal Unit |
|---|---|
| Location | 200 Lothrop Street, Pittsburgh, Pennsylvania |
| No. of Dialysis Stations | 12 |
| Medicare ID | 390164 |
| Managed By | Upmc Health System |
| Ownership Type | Non-Profit |
| Late Shifts | Yes |
| 200 Lothrop Street, Pittsburgh, Pennsylvania, 15213 | |
| (412) 647-3114 | |
| Not Available |
News Archive
Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners annual congress in Glasgow, UK that primary care doctors will not be able to cope with the rising demand for cancer care in high-income countries – predicted to double within the next 15 years.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Fears of confirming stereotypes about pregnant workers as incompetent, weak, or less committed to their job can drive pregnant employees to work extra hard, risking injury.
› Verified 1 days ago
| NPI Number | 1053471656 |
| Doing Business As | Upmc Presbyterian Shadyside |
| Address | 200 Lothrop St Pittsburgh, Pennsylvania, 15213 |
| Phone Number | (412) 432-5500 |
News Archive
Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners annual congress in Glasgow, UK that primary care doctors will not be able to cope with the rising demand for cancer care in high-income countries – predicted to double within the next 15 years.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Fears of confirming stereotypes about pregnant workers as incompetent, weak, or less committed to their job can drive pregnant employees to work extra hard, risking injury.
› Verified 1 days ago
| NPI Number | 1083851968 |
| Doing Business As | Upmc Children's Hospital Of Pittsburgh |
| Address | 4401 Penn Ave Pittsburgh, Pennsylvania, 15224 |
| Phone Number | (412) 432-5000 |
News Archive
Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners annual congress in Glasgow, UK that primary care doctors will not be able to cope with the rising demand for cancer care in high-income countries – predicted to double within the next 15 years.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Fears of confirming stereotypes about pregnant workers as incompetent, weak, or less committed to their job can drive pregnant employees to work extra hard, risking injury.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 1 |
News Archive
Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners annual congress in Glasgow, UK that primary care doctors will not be able to cope with the rising demand for cancer care in high-income countries – predicted to double within the next 15 years.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Fears of confirming stereotypes about pregnant workers as incompetent, weak, or less committed to their job can drive pregnant employees to work extra hard, risking injury.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 7 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 39 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners annual congress in Glasgow, UK that primary care doctors will not be able to cope with the rising demand for cancer care in high-income countries – predicted to double within the next 15 years.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Fears of confirming stereotypes about pregnant workers as incompetent, weak, or less committed to their job can drive pregnant employees to work extra hard, risking injury.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Upmc Presbyterian - Renal Unit with elevated calcium levels.
| Patients with hypercalcemia | 11 |
| Hypercalcemia patient months | 76 |
| Patients with Serumphosphor | 7 |
| Patients with Serumphosphor less than 3.5 mg/dL | |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | |
| Patients with Serumphosphor greater than 7 mg/dL |
News Archive
Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners annual congress in Glasgow, UK that primary care doctors will not be able to cope with the rising demand for cancer care in high-income countries – predicted to double within the next 15 years.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Fears of confirming stereotypes about pregnant workers as incompetent, weak, or less committed to their job can drive pregnant employees to work extra hard, risking injury.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 86 |
| Patient months included in arterial venous fistula and catheter summaries | 127 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 69 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 16 |
News Archive
Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners annual congress in Glasgow, UK that primary care doctors will not be able to cope with the rising demand for cancer care in high-income countries – predicted to double within the next 15 years.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Fears of confirming stereotypes about pregnant workers as incompetent, weak, or less committed to their job can drive pregnant employees to work extra hard, risking injury.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 5 |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
Leading primary care professionals and cancer experts will warn at the Royal College of General Practitioners annual congress in Glasgow, UK that primary care doctors will not be able to cope with the rising demand for cancer care in high-income countries – predicted to double within the next 15 years.
Psilocybin, a psychedelic drug believed to help rewire the brain, is now being studied to relieve treatment-resistant depression at The University of Texas Health Science Center at Houston (UTHealth) as part of a global Phase II clinical trial.
The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 diabetics, based on research by Dr. Eli Lewis of Israel's Ben-Gurion University of the Negev.
Fears of confirming stereotypes about pregnant workers as incompetent, weak, or less committed to their job can drive pregnant employees to work extra hard, risking injury.
› Verified 1 days ago